Summary

Dr. Casal-Dominguez is currently a Postdoctoral Researcher at NIAMS (NIH). She joined the NIH after working as a Research Fellow at the Rheumatology Department of the Johns Hopkins Hospital between September 2015 and September 2016.

Dr. Casal-Dominguez graduated from Santiago de Compostela School of Medicine and completed her Family Medicine Residency training at the Mar Hospital and the Clot Primary Care Centre in Barcelona.

Research Statement

Dr. Casal-Dominguez's major areas of research are Immunology and Rheumatology (especially inflammatory myositis).

Scientific Publications

High-resolution manometry in patients with idiopathic inflammatory myopathy: Elevated prevalence of esophageal involvement and differences according to autoantibody status and clinical subset.

Casal-Dominguez M, Pinal-Fernandez I, Mego M, Accarino A, Jubany L, Azpiroz F, Selva-O'callaghan A
Muscle & nerve.
2017 Sep;
56(3).
doi: 10.1002/mus.25507
PMID: 27935079

A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies.

Pinal-Fernandez I, Casal-Dominguez M, Huapaya JA, Albayda J, Paik JJ, Johnson C, Silhan L, Christopher-Stine L, Mammen AL, Danoff SK
Rheumatology (Oxford, England).
2017 Jun 1;
56(6).
doi: 10.1093/rheumatology/kex021
PMID: 28339994

Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity.

Pinal-Fernandez I, Casal-Dominguez M, Carrino JA, Lahouti AH, Basharat P, Albayda J, Paik JJ, Ahlawat S, Danoff SK, Lloyd TE, Mammen AL, Christopher-Stine L
Annals of the rheumatic diseases.
2017 Apr;
76(4).
doi: 10.1136/annrheumdis-2016-210198
PMID: 27651398

Advancing the Development of Patient-reported Outcomes for Adult Myositis at OMERACT 2016: An International Delphi Study.

Park JK, Mecoli CA, Alexanderson H, Regardt M, Christopher-Stine L, Casal-Domínguez M, de Groot I, Sarver C, Lundberg IE, Bingham CO 3rd, Song YW
The Journal of rheumatology.
2017 Nov;
44(11).
doi: 10.3899/jrheum.161252
PMID: 28765245

Statins: pros and cons.

Pinal-Fernandez I, Casal-Dominguez M, Mammen AL
Medicina clinica.
2018 May 23;
150(10).
doi: 10.1016/j.medcli.2017.11.030
PMID: 29292104

Immune-Mediated Necrotizing Myopathy.

Pinal-Fernandez I, Casal-Dominguez M, Mammen AL
Current rheumatology reports.
2018 Mar 26;
20(4).
doi: 10.1007/s11926-018-0732-6
PMID: 29582188

Muscular and extramuscular clinical features of patients with anti-PM/Scl autoantibodies.

De Lorenzo R, Pinal-Fernandez I, Huang W, Albayda J, Tiniakou E, Johnson C, Milisenda JC, Casal-Dominguez M, Corse AM, Danoff SK, Christopher-Stine L, Paik JJ, Mammen AL
Neurology.
2018 Jun 5;
90(23).
doi: 10.1212/WNL.0000000000005638
PMID: 29728522

Advancing the Development of Patient-reported Outcomes for Adult Myositis at OMERACT 2016: An International Delphi Study.

Park JK, Mecoli CA, Alexanderson H, Regardt M, Christopher-Stine L, Casal-Domínguez M, de Groot I, Sarver C, Lundberg IE, Bingham CO 3rd, Song YW
The Journal of rheumatology.
2018 Jul;
45(7).
doi: 10.3899/jrheum.161252.C2
PMID: 29961681

Education

Dr. Casal-Dominguez earned her MD at Santiago de Compostela University (Santiago de Compostela, Spain) in 2010. In 2016, she got her PhD degree at Barcelona University (Barcelona, Spain).

Experience

Dr. Casal-Dominguez completed her Residency in Family Medicine in Barcelona (Spain) (2011-2015) and has been working as a Postdoctoral Fellow in NIAMS since 2017.

Last Updated: June 2020